Challenge
A leading pharmaceutical company sought to increase awareness and referrals for its newly approved treatment for a rare pediatric genetic disorder. The primary goal was to educate healthcare providers (HCPs), particularly general pediatricians, about the treatment and encourage them to refer eligible patients to specialists such as pediatric endocrinologists and geneticists for further evaluation and potential therapy. In the context of a crowded and complex rare disease landscape, the company faced the challenge of precisely targeting the most relevant HCPs, delivering timely and impactful educational content at the point of care, and effectively measuring the resulting impact on referral patterns.